Apalutamide Patent Expiration
Apalutamide is Used for treating various forms of prostate cancer, including non-metastatic and metastatic types, in combination with different therapies. It was first introduced by Janssen Biotech Inc
Apalutamide Patents
Given below is the list of patents protecting Apalutamide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Erleada | US11963952 | Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer | Jan 30, 2040 | Janssen Biotech |
| Erleada | US10702508 | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer | Apr 30, 2038 | Janssen Biotech |
| Erleada | US10052314 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Sep 23, 2033 | Janssen Biotech |
| Erleada | US10849888 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Sep 23, 2033 | Janssen Biotech |
| Erleada | US9884054 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Sep 23, 2033 | Janssen Biotech |
| Erleada | USRE49353 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Sep 23, 2033 | Janssen Biotech |
| Erleada | US9481663 | Crystalline forms of an androgen receptor modulator | Jun 04, 2033 | Janssen Biotech |
| Erleada | US8445507 | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases | Sep 15, 2030 | Janssen Biotech |
| Erleada | US8802689 | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases | Mar 27, 2027 | Janssen Biotech |
| Erleada | US9388159 | Substituted diazaspiroalkanes as androgen receptor modulators | Mar 27, 2027 | Janssen Biotech |
| Erleada | US9987261 | Substituted diazaspiroalkanes as androgen receptor modulators | Mar 27, 2027 | Janssen Biotech |
Apalutamide's Family Patents
Explore Our Curated Drug Screens
Apalutamide Generic API Manufacturers
Only one generic application has been filed for Apalutamide.
Given below is the list of companies who have filed for Apalutamide generic, along with the locations of their manufacturing plants worldwide.
1. ZYDUS
Zydus Worldwide Dmcc has filed for 1 generic for Apalutamide. Given below are the details of the strengths of this generic introduced by Zydus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Prescription | ORAL | AB | Mar 17, 2025 |
Manufacturing Plant Locations New
Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||